Clinical Analysis of Transcatheter Arterial Chemoembolization Combined with Intensity Modulated Radiotherapy Therapy for Patients with Primary Hepatic Carcinoma

Gao Jing Yan; Chen Fu Kun; Yan Jia Wen; Wang Jia Ping

Volume 38 Issue 01

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2017 > 38(01): 95-98

Gao Jing Yan , Chen Fu Kun , Yan Jia Wen , Wang Jia Ping . Clinical Analysis of Transcatheter Arterial Chemoembolization Combined with Intensity Modulated Radiotherapy Therapy for Patients with Primary Hepatic Carcinoma[J]. Journal of Kunming Medical University, 2017, 38(01): 95-98.

Citation:

Gao Jing Yan , Chen Fu Kun , Yan Jia Wen , Wang Jia Ping . Clinical Analysis of Transcatheter Arterial Chemoembolization Combined with Intensity Modulated Radiotherapy Therapy for Patients with Primary Hepatic Carcinoma[J]. Journal of Kunming Medical University, 2017, 38(01): 95-98.

Citation:

Gao Jing Yan , Chen Fu Kun , Yan Jia Wen , Wang Jia Ping . Clinical Analysis of Transcatheter Arterial Chemoembolization Combined with Intensity Modulated Radiotherapy Therapy for Patients with Primary Hepatic Carcinoma[J]. Journal of Kunming Medical University, 2017, 38(01): 95-98.

PDF( 171 KB)

Clinical Analysis of Transcatheter Arterial Chemoembolization Combined with Intensity Modulated Radiotherapy Therapy for Patients with Primary Hepatic Carcinoma

Funds:

基金：云南省科技厅应用基础研究基金资助项目 (2009ZC111M); 云南省教育厅科学研究基金资助项目 (09Z0034);

Received Date: 2016-10-20

Abstract

Abstract

Objective To evaluate the efficacy of transcatheter arterial chemoembolization (TACE) in combination with intensity modulated radiotherapy (IMRT) in treatment of primary hepatic carcinoma (PHC) .Methods All 68 patients with PHC were randomized into treatment group (TACE plus IMRT) and control group (TACE alone) , with 34 cases in each group.Patients in the control group were treated with interventional therapy alone.Patients in the treatment group were treated with interventional therapy (transcatheter arterial chemoembolization) plus radiotherapy.Treatment group patients firstly received 2 to 3 times interventional therapy, then followed by radiotherapy with 2 to 4 week interval.Results The short-term efficacy was 82.4% in treatment group which was significantly higher than 61.8% in control group (P<0.05) .The survival rate was 76.5% in 1 year and55.9% in 2 years in treatment group, 58.9% and 32.4% in control group respectively.The difference between 2group was statistical significance (P<0.05) No serious toxicities were observes in the patients of the two groups.Conclusion The results suggest that the treatment effect of TACE plus IMRT is better than interventional therapy alone for patients with primary Hepatic carcinoma, and has well tolerance and fewer adverse reactions.
- Primary hepatic carcinoma (PHC) ,
- Radiotherapy,
- Interventional therapy,
- Transcatheter arterial chemoembolization (TACE) ,
- Intensity modulated radiotherapy (IMRT)

FullText(HTML)

References(11)

References

[1]	[1]HUBNER M, MCCORMACK L, CLAVIEN P A.Surgical therapy of liver tumors:resection vs ablation[J].Schweiz Rundsch Med Prax, 2005, 94 (33) :1255.
[2]	[2]KOKUDO N, MAKUUCHI M.Current role of portal vein embolization/hepatic artery chemoembolizatior[J].Surg Clin North Am, 2004, 8 (2) :643.
[3]扬秉辉, 夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志, 200l, 9 (6) :324.
[4]周蔼斌, 周俊平.细胞因子及其信号通路在放射性肝损伤发病中的作用研究进展[J].实用肝脏病杂志, 2016, 19 (6) :766-769.
[5]黄丹丹, 罗杨坤, 杨家林.晚期肝癌调强适形放射治疗的疗效及预后分[J].西部医学, 2011, 23 (4) :621-623.
[6]孙燕, 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社, 1996:102-140.
[7]	[7]HEE C P, JINSIL S, KWANG H H, et al.Dose-response relationship in radiotherapy for hepatocellular carcinoma[J].Int J Radia Oncol Biol Phys, 2002, 54 (1) :150-155.
[8]	[8]CHANG Y, YANG Z Y, LI G L, et al.Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer:a comparison of3DCRT, IMRT, and rapid ARC[J].Int J Gynecol Cancer, 2016, 26 (4) :770-776.
[9]王家平, 章树乔.介入联合γ刀治疗原发性肝癌的疗效分析[J].实用放射学杂志, 2009, 25 (3) :405-406.
[10]耿长新, 曾昭冲, 王吉耀, 等.多烯紫杉醇在体内对肝癌的抑制和放疗增敏及其作用[J].中华肝病杂志, 2005, 13 (1) :60-61.
[11]张立洁, 彭泉, 芦东徽, 等.三维适形放疗联合TACE治疗肝癌并发门静脉癌栓疗效的Meta分析[J].实用肝脏病杂志, 2015, 18 (3) :254-257.

Relative Articles(20)

Relative Articles

[1]	Yuanzhen WANG, Hongyan WEI, Renhai TIAN, Yongzhen Chen, Danqing XU, Yingyuan ZHANG, Lixian CHANG, Chunyun LIU, Li LIU. Establishment and Evaluation of a Risk Prediction Model for Chronic Liver Failure Complicated by Primary Hepatocellular Carcinoma Before Intervention. Journal of Kunming Medical University, 2025, 46(3): 1-9.
[2]	Lei CHEN, Tong TANG, Daizhong ZHANG, Fengling LIU, Zhongqiu YANG, Huan YAN. Effect of Precise Hepatic Pedicle Dissection Assisted Laparoscopic Hepatectomy and Its Impact on Inflammatory Immune Stress and Liver Function. Journal of Kunming Medical University, 2024, 45(4): 120-127. doi: 10.12259/j.issn.2095-610X.S20240417
[3]	Ying ZHANG, Fengxia YANG, Jing GUO, Qingling ZHANG. Effects of Systematic Psychological Intervention Based on S-ABC Framework on Perioperative Psychological Distress and Immune Function in Patients with Primary Liver Cancer. Journal of Kunming Medical University, 2023, 44(11): 170-174. doi: 10.12259/j.issn.2095-610X.S20231126
[4]	Qianting DUAN, Guanshun WANG, Rong DING, Na WANG, Hongli CUN, Ling YANG. Application of CT Radiomics in the Short-Term Prognosis of Combined Therapy for Hepatocellular Carcinoma. Journal of Kunming Medical University, 2023, 44(1): 128-134. doi: 10.12259/j.issn.2095-610X.S20220818
[5]	Haiyan FU, Junfang YAN, Hongjuan LI, Lin WANG, Jie ZHANG, Yujun ZHOU, Bin XU, Yu LUO. Effect of Time Interval on the Outcome with Transarterial Chemoembolization Followed Microwave Ablation with Hepatocellular Carcinoma. Journal of Kunming Medical University, 2022, 43(11): 63-70. doi: 10.12259/j.issn.2095-610X.S20221127
[6]	Ying ZHANG, Jing GUO, Tao FENG, Yan ZHOU, Yao HUANG, Xiao-feng DENG, LU ZHENG. Shared Decision-making in Patients with Primary Liver Cancer During Perioperative Period. Journal of Kunming Medical University, 2021, 42(8): 177-180. doi: 10.12259/j.issn.2095-610X.S20210832
[7]	Xiao-biao MA, Feng LUO, Yong-liang GAO, Jing-chao HAO. Clinical Study of Chemotherapy Combined with CIK Cell Immunotherapy for Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2020, 41(12): 60-67. doi: 10.12259/j.issn.2095-610X.S20201215
[8]	Tian Bo Yan , Yang Qin Ling , Zhang Jiao Qiong , Han Na , Liu Shao Hua . The Curative Effect of Auxiliary Hepatic Arterial Chemoembolization in the Treatment of Microvascular Invasion of Hepatocellular Carcinoma. Journal of Kunming Medical University, 2018, 39(08): 86-92.
[9]	Xie Qing Yun , Lei Ze Hua , Gao Feng Wei , Jiang Kang Yi . . Journal of Kunming Medical University, 2018, 39(10): 101-104.
[10]	Tong Yu Yun . Clinical Application of Iodine Oil-Docetaxel-Suspension in Transcatheter Arterial Chemoembolization for Primary Hepatic Carcinoma. Journal of Kunming Medical University,
[11]	Zhang Ai Ling . Conventional Segmentation and Large Fractionated Three-dimensional Conformal Radiotherapy in the Treatment of Non Small Cell Lung Cancer with Superior Vena Cava Syndrome. Journal of Kunming Medical University,
[12]	Jiang Mei Ping . . Journal of Kunming Medical University,
[13]	He Zhi Jiang . . Journal of Kunming Medical University,
[14]	Wu Xing Rao . . Journal of Kunming Medical University,
[15]	Zhang Jie . . Journal of Kunming Medical University,
[16]	Guo Xi . . Journal of Kunming Medical University,
[17]	. Clinical Observation of Radiotherapy Combined with Zoledronic Acid in the Treatment of Patients with Bone Metastases Pain. Journal of Kunming Medical University,
[18]	. Therapeutic Effect of Transcatheterhepatic Arterial Chemoembolization(TACE)Combined with Operation on 96 Cases of Primary Hepatic Carcinoma. Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Hao Jin Gang . . Journal of Kunming Medical University,